OPKO Health Inc. (OPK)
The price, the headline numbers and the latest news, in one place.
OPKO Health Inc. (OPK) Stock Price, Analysis & Data
| Bid | 1.28 |
| Market Cap | 1.1B |
| Revenue (ttm) | 587.9M |
| Net Income (ttm) | -72.89M |
| 1.49 | |
| -0.07 | |
| n/a | |
| -5.38 | |
| P/B (ttm) | 0.93 |
| P/S (ttm) | 1.88 |
| Earnings Date | Oct 28, 2026 |
| Ask | 1.49 |
| Volume | 2,413,964 |
| Avg. Volume (20D) | 3,491,695 |
| Open | 1.49 |
| Previous Close | 1.50 |
| Day's Range | 1.46 - 1.50 |
| 52-Week Range | 0.98 - 1.73 |
| Analyst | Buy |
| Price Target | 3 (102.70%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OPK
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical tria...
Financial Performance
In 2025, OPKO Health's revenue was 606.88M, a decrease of -14.9% compared to the previous year's 713.14M. Earnings were -225.68M, an increase of 324.02%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for OPK stock is "Buy". The 12-month stock price forecast is 3, which is upside of 102.7% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $163.58M misses estimates by $0, with 4.32% YoY growth.
- EPS of -0.03 exceeds estimates by 0.08, with 62.50% YoY growth.
Analysts project revenue of ... Upgrade
